De novo daptomycin-nonsusceptible enterococcal infections

scientific article published in April 2012

De novo daptomycin-nonsusceptible enterococcal infections is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.3201/EID1804.110932
P932PMC publication ID3309676
P698PubMed publication ID22469288
P5875ResearchGate publication ID223981914

P50authorTheodoros KelesidisQ37830063
P2093author name stringRomney Humphries
Daniel Z Uslan
David Pegues
P2860cites workMultidrug-Resistant Staphylococcus aureus in US Meat and PoultryQ24612676
Genetic basis for daptomycin resistance in enterococciQ33876255
Animal antibiotic use has an early but important impact on the emergence of antibiotic resistance in human commensal bacteriaQ34029641
In vivo transfer of the vanA resistance gene from an Enterococcus faecium isolate of animal origin to an E. faecium isolate of human origin in the intestines of human volunteersQ34352068
Antibiotic usage and risk of colonization and infection with antibiotic-resistant bacteria: a hospital population-based study.Q37392912
Contamination rates and antimicrobial resistance in bacteria isolated from "grass-fed" labeled beef productsQ42975071
De novo daptomycin nonsusceptibility in a clinical isolateQ43234409
Daptomycin nonsusceptible enterococci: an emerging challenge for cliniciansQ44579110
Comment on: Successful therapy of treatment-emergent, non-clonal daptomycin-non-susceptible Enterococcus faecium infectionsQ58390313
Daptomycin-resistant Enteroccoccus faecium in a patient with no prior exposure to daptomycinQ79816410
P433issue4
P304page(s)674-676
P577publication date2012-04-01
P1433published inEmerging Infectious DiseasesQ5235761
P1476titleDe novo daptomycin-nonsusceptible enterococcal infections
P478volume18

Reverse relations

cites work (P2860)
Q37263289A current perspective on daptomycin for the clinical microbiologist
Q37026557A liaF codon deletion abolishes daptomycin bactericidal activity against vancomycin-resistant Enterococcus faecalis
Q90502080A mutation in the glycosyltransferase gene lafB causes daptomycin hypersusceptibility in Enterococcus faecium
Q38263035Antibacterial resistance: an emerging 'zoonosis'?
Q92000710Antimicrobial resistance in nephrology
Q91824292Antimicrobial sensing coupled with cell membrane remodeling mediates antibiotic resistance and virulence in Enterococcus faecalis
Q36217683Daptomycin exposure precedes infection and/or colonization with daptomycin non-susceptible enterococcus
Q26851754Daptomycin for the treatment of bacteraemia due to vancomycin-resistant enterococci
Q44773902Daptomycin nonsusceptible enterococci in hematologic malignancy and hematopoietic stem cell transplant patients: an emerging threat
Q40254524Daptomycin nonsusceptible vancomycin resistant Enterococcus bloodstream infections in patients with hematological malignancies: risk factors and outcomes
Q38023801Dendrimers--revolutionary drugs for infectious diseases.
Q44602409Evolution of high-level daptomycin resistance in Enterococcus faecium during daptomycin therapy is associated with limited mutations in the bacterial genome.
Q92068591Genomics of vancomycin-resistant Enterococcus faecium
Q41570641Genotypic and phenotypic evaluation of the evolution of high-level daptomycin nonsusceptibility in vancomycin-resistant Enterococcus faecium
Q34058360Identification of a novel clone, ST736, among Enterococcus faecium clinical isolates and its association with daptomycin nonsusceptibility
Q35746209In vitro activity of daptomycin in combination with β-lactams, gentamicin, rifampin, and tigecycline against daptomycin-nonsusceptible enterococci
Q30277034Influence of Minimum Inhibitory Concentration in Clinical Outcomes of Enterococcus faecium Bacteremia Treated With Daptomycin: Is it Time to Change the Breakpoint?
Q26779944Mechanisms of drug resistance: daptomycin resistance
Q42266721Proximity to animal or crop operations may be associated with de novo daptomycin-non-susceptible Enterococcus infection
Q41578863Saponins increase susceptibility of vancomycin-resistant enterococci to antibiotic compounds
Q38166035The zoonotic potential of daptomycin non-susceptible enterococci
Q58390298Transport of daptomycin resistance genes between animals and humans as a possible mechanism for development of de novo daptomycin resistance in enterococci
Q89241328Variability of Daptomycin MIC Values for Enterococcus faecium When Measured by Reference Broth Microdilution and Gradient Diffusion Tests

Search more.